Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching ...

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing her ...

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...

Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.

Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message to all ...

However, she will continue to look after the day-to-day operations of the IT services and consulting firm during the ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...